Eukaryotic translation elongation factor 1 alpha 1 pseudogene 50 (EEF1A1P50)

EEF1A1P50 is a processed pseudogene derived from the parental EEF1A1 gene, which encodes a core translation elongation factor involved in the GTP-dependent binding of aminoacyl-tRNA to the ribosomal A-site during peptide synthesis[1][2][3]. Like most EEF1A1 pseudogenes, EEF1A1P50 does not encode a functional protein and is not currently known to be expressed, to influence gene regulation, or to be associated with any disease or therapeutic modality[1][2]. The functional significance of most EEF1A1 pseudogenes, including EEF1A1P50, remains undetermined, and there are no published experimental studies or clinical associations pertaining to EEF1A1P50. The parental gene EEF1A1 has some pseudogenes with possible regulatory roles described in the literature, typically in the context of gene expression modulation or disease association, but these examples are rare and primarily specific to certain pseudogenes (e.g., EEF1A1P1, EEF1A1P9)[1][2]. The majority of human pseudogenes—including EEF1A1P50—are poorly characterized, with many having no known expression or pathological significance[1]. Pseudogenes as a class have been postulated as potential biomarkers or regulators in certain cancers, but there is no evidence for EEF1A1P50 serving such a role[5]. If further structure or new canonical forms are required, additional genomic analysis or functional studies would be needed, but at present, EEF1A1P50 is best considered a non-functional pseudogene with no established significance[1][2].

Other names

EEF1A1P50